Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04713514 |
Title | OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC (TEDOVA) |
Acronym | TEDOVA |
Recruitment | Recruiting |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | ARCAGY/ GINECO GROUP |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | FRA | DEU | BEL |